Table 4 Drug-related adverse events

From: Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer

 

Arm A ( n =50)

Arm B ( n =51)

 

G1/2

G3

G1/2

G3

 

No. (%)

No. (%)

No. (%)

No. (%)

Leukopenia

17 (34)

3 (6)

20 (39)

3 (6)

Neutropenia

12 (24)

 

11 (22)

4 (8)

Thrombocytepenia

9 (18)

 

9 (18)

 

Anaemia

13 (26)

 

17 (33)

1 (2)

Elevation of Bilirubin

7 (14)

 

7 (14)

2 (4)

Elevation of ALT, AST

7 (14)

 

8 (16)

1 (2)

Anorexia

14 (28)

 

14 (27)

 

Nausea and vomiting

7 (14)

 

15 (29)

 

Diarrhoea

4 (8)

1 (2)

12 (24)

2 (4)

Stomatitis

6 (12)

 

3 (6)

1 (2)

Other GI toxicity

3 (6)

 

2 (4)

 

Cutaneous symptoms

9 (18)

 

19 (37)

 

Peripheral neuropathy

1 (2)

 

2 (4)

 

Dizziness

2 (4)

1 (2)

2 (4)

 

General fatigue

10 (20)

 

6 (12)

 

Others

8 (16)

 

2 (4)